LABS.L

Life Science Reit PLC [LABS.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

LABS.L Stock Summary

Top 10 Correlated ETFs

LABS.L


Top 10 Correlated Stocks

LABS.L


In the News

LABS.L Financial details

Company Rating
Buy
Market Cap
152.6M
Income
-
Revenue
-
Book val./share
0.9
Cash/share
0.06
Dividend
0.03
Dividend %
0.05%
Employees
-
Optionable
No
Shortable
Yes
Earnings
19 Sep 2024
P/E
-8.06
Forward P/E
-
PEG
-
P/S
-11.17
P/B
0.7
P/C
655
P/FCF
-204.6
Quick Ratio
20.42
Current Ratio
20.42
Debt / Equity
0.31
LT Debt / Equity
0.32
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
-458.64%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
4.37%
EPS Q/Q
-115.42%
-
-
-
-
SMA20
-8.7%
SMA50
-32.26%
SMA100
-34.38%
Inst Own
-
Inst Trans
-
ROA
-6%
ROE
-8%
ROC
-0.06%
Gross Margin
100%
Oper. Margin
138%
Profit Margin
139%
Payout
-13%
Shs Outstand
350M
Shs Float
334.1M
-
-
-
-
Target Price
-
52W Range
40.6-77.4
52W High
-48.96%
52W Low
-1.75%
RSI
25
Rel Volume
1.06
Avg Volume
817.01K
Volume
868.56K
Perf Week
-6.43%
Perf Month
-18.8%
Perf Quarter
-43.37%
Perf Half Y
-45.72%
-
-
-
-
Beta
0.163
-
-
Volatility
1.56%, 2.31%
Prev Close
-2%
Price
39.3
Change
-4.73%

LABS.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2021-12-31 2022-12-31
2.02K2.02K
Revenue per share
0.02-0.06
Net income per share
0.02-0.08
Operating cash flow per share
0.010
Free cash flow per share
0.01-0.02
Cash per share
0.470.03
Book value per share
10.91
Tangible book value per share
10.91
Share holders equity per share
10.91
Interest debt per share
00.43
Market cap
354.38M253.05M
Enterprise value
188.41M352.28M
P/E ratio
45.78-9.16
Price to sales ratio
43.64-12.7
POCF ratio
100.16-232.58
PFCF ratio
100.16-28.99
P/B Ratio
1.010.79
PTB ratio
1.010.79
EV to sales
23.2-17.68
Enterprise value over EBITDA
24.34-12.83
EV to operating cash flow
53.25-323.78
EV to free cash flow
53.25-40.36
Earnings yield
0.02-0.11
Free cash flow yield
0.01-0.03
Debt to equity
00.46
Debt to assets
00.33
Net debt to EBITDA
-21.44-3.61
Current ratio
020.42
Interest coverage
0-7.26
Income quality
0.460.04
Dividend Yield
00.01
Payout ratio
0-0.13
Sales general and administrative to revenue
0.05-0.38
Research and developement to revenue
00
Intangibles to total assets
00
Capex to operating cash flow
07.02
Capex to revenue
00.38
Capex to depreciation
00
Stock based compensation to revenue
00
Graham number
0.711.27
ROIC
0.02-0.06
Return on tangible assets
0.02-0.06
Graham Net
0.69-0.23
Working capital
166.94M19.95M
Tangible asset value
350.58M319.45M
Net current asset value
156.12M-107.4M
Invested capital
00.46
Average receivables
05.67M
Average payables
0513.5K
Average inventory
0111.91M
Days sales outstanding
44.14-189.94
Days payables outstanding
043.81
Days of inventory on hand
134.64K2.39K
Receivables turnover
8.27-1.92
Payables turnover
08.33
Inventory turnover
00.15
ROE
0.02-0.09
Capex per share
0-0.02

Quarterly Fundamentals Overview

Last date of statement is 2023-06-30 for Q2

Metric History 2021-09-302022-06-302022-12-31 2023-06-30
2.02K2.02K2.02K2.02K
Revenue per share
000.030.03
Net income per share
00-0.10.02
Operating cash flow per share
000.010.01
Free cash flow per share
00-0.01-0.01
Cash per share
000.030.06
Book value per share
000.910.9
Tangible book value per share
000.910.9
Share holders equity per share
000.910.9
Interest debt per share
000.430.3
Market cap
00253.05M238M
Enterprise value
038.13M352.28M318.94M
P/E ratio
00-1.8311.19
Price to sales ratio
0026.7924.15
POCF ratio
0077.2455.37
PFCF ratio
00-58.24-52.83
P/B Ratio
000.790.76
PTB ratio
000.790.76
EV to sales
0037.332.36
Enterprise value over EBITDA
0078.0968.94
EV to operating cash flow
00107.5374.21
EV to free cash flow
00-81.08-70.8
Earnings yield
00-0.140.02
Free cash flow yield
00-0.02-0.02
Debt to equity
00.270.460.31
Debt to assets
00.20.330.22
Net debt to EBITDA
002217.5
Current ratio
0108.2820.4217.76
Interest coverage
001.040.79
Income quality
00-0.090.81
Dividend Yield
000.010.04
Payout ratio
00-0.11.97
Sales general and administrative to revenue
0000
Research and developement to revenue
0000
Intangibles to total assets
0000
Capex to operating cash flow
00-2.33-2.05
Capex to revenue
00-0.81-0.89
Capex to depreciation
0000
Stock based compensation to revenue
0000
Graham number
001.420.55
ROIC
000.010.01
Return on tangible assets
00-0.080.01
Graham Net
00-0.23-0.25
Working capital
167.16M19.95M23.84M
Tangible asset value
1357.46M319.45M314.27M
Net current asset value
1-57.86M-107.4M-98.76M
Invested capital
00.270.460.31
Average receivables
0000
Average payables
0000
Average inventory
0000
Days sales outstanding
0098.7953.98
Days payables outstanding
0020.8625.94
Days of inventory on hand
001.14K495.42
Receivables turnover
000.911.67
Payables turnover
004.313.47
Inventory turnover
000.080.18
ROE
00-0.110.02
Capex per share
00-0.02-0.03

LABS.L Frequently Asked Questions

What is Life Science Reit PLC stock symbol ?

Life Science Reit PLC is a GB stock and trading under the symbol LABS.L

What is Life Science Reit PLC stock quote today ?

Life Science Reit PLC stock price is $39.3 today.

Is Life Science Reit PLC stock public?

Yes, Life Science Reit PLC is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap